Evidence map›Paper›PMID 25951442›Full record

ArticlePLoS pathogens2015

Staphylococcus aureus Survives with a Minimal Peptidoglycan Synthesis Machine but Sacrifices Virulence and Antibiotic Resistance.

Patricia Reed, Magda L Atilano, Renato Alves, Egbert Hoiczyk, Xinwei Sher, Nathalie T Reichmann, Pedro M Pereira, Terry Roemer, Sérgio R Filipe, José B Pereira-Leal and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Control of morphogenesis during theScience advances · 2025
    Article
  8. Bacterial and host interactions inFrontiers in microbiology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Bacterial growth dynamics in a rhythmic symbiosis.Molecular biology of the cell · 2024
    Article
  15. Article
  16. Toolbox of Characterized Genetic Parts forACS synthetic biology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. GFP fusions of Sec-routed extracellular proteins inMicrobial cell (Graz, Austria) · 2023
    Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Patricia ReedLaboratory of Bacterial Cell Biology, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
Magda L AtilanoLaboratory of Bacterial Cell Surface and Pathogenesis, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal; Laboratory of Genes and Development, Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
Renato AlvesInstituto Gulbenkian de Ciência, Oeiras, Portugal.
Egbert HoiczykW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America; The University of Sheffield, Department of Molecular Biology and Biotechnology, Western Bank, Sheffield, United Kingdom.
Xinwei SherMerck Research Laboratories IT, Boston, Massachusetts, United States of America.
Nathalie T ReichmannLaboratory of Bacterial Cell Biology, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
Pedro M PereiraLaboratory of Bacterial Cell Biology, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
Terry RoemerInfectious Disease Research, Merck Research Laboratories, Kenilworth, New Jersey, United States of America.
Sérgio R FilipeLaboratory of Bacterial Cell Surface and Pathogenesis, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
José B Pereira-LealInstituto Gulbenkian de Ciência, Oeiras, Portugal.
Petros LigoxygakisLaboratory of Genes and Development, Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
Mariana G PinhoLaboratory of Bacterial Cell Biology, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
Universidade Nova de Lisboa · PTInstituto Gulbenkian de Ciência · PTMerck & Co., Inc., Rahway, NJ, USA (United States) · USUniversity of Oxford · GBUniversity of Sheffield · GB

Funding

Novel ParP Pilus of Myxococcus XanthusR01GM085024 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI HOICZYK, EGBERT · 2008 to 2012
$1.6M
Medical Research Council G0300170NIGMS NIH HHS GM85024NIGMS NIH HHS R01 GM085024
6 · The paper itself

Abstract

Many important cellular processes are performed by molecular machines, composed of multiple proteins that physically interact to execute biological functions. An example is the bacterial peptidoglycan (PG) synthesis machine, responsible for the synthesis of the main component of the cell wall and the target of many contemporary antibiotics. One approach for the identification of essential components of a cellular machine involves the determination of its minimal protein composition. Staphylococcus aureus is a Gram-positive pathogen, renowned for its resistance to many commonly used antibiotics and prevalence in hospitals. Its genome encodes a low number of proteins with PG synthesis activity (9 proteins), when compared to other model organisms, and is therefore a good model for the study of a minimal PG synthesis machine. We deleted seven of the nine genes encoding PG synthesis enzymes from the S. aureus genome without affecting normal growth or cell morphology, generating a strain capable of PG biosynthesis catalyzed only by two penicillin-binding proteins, PBP1 and the bi-functional PBP2. However, multiple PBPs are important in clinically relevant environments, as bacteria with a minimal PG synthesis machinery became highly susceptible to cell wall-targeting antibiotics, host lytic enzymes and displayed impaired virulence in a Drosophila infection model which is dependent on the presence of specific peptidoglycan receptor proteins, namely PGRP-SA. The fact that S. aureus can grow and divide with only two active PG synthesizing enzymes shows that most of these enzymes are redundant in vitro and identifies the minimal PG synthesis machinery of S. aureus. However a complex molecular machine is important in environments other than in vitro growth as the expendable PG synthesis enzymes play an important role in the pathogenicity and antibiotic resistance of S. aureus.

Indexed as

Drug Resistance, Multiple, BacterialAnimalsAnti-Bacterial AgentsBacterial ProteinsCell WallDrosophila melanogasterGene DeletionGene Expression Regulation, BacterialHost-Pathogen InteractionsInsect ProteinsMethicillin-Resistant Staphylococcus aureusMicrobial ViabilityMutationPenicillin-Binding ProteinsPeptidoglycanPeptidoglycan GlycosyltransferaseAnti-Bacterial AgentsBacterial ProteinsInsect ProteinsPenicillin-Binding ProteinsPeptidoglycanPeptidoglycan Glycosyltransferasepeptidoglycan receptorPeptidyl TransferasesReceptors, Cell SurfaceRecombinant Proteins

Identifiers

PMID25951442
PMCPMC4423922
OpenAlexW304376472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.